Skip to main content
Equibles

Vanessa Kanu

CFO

Aptargroup, Inc. (ATR)

Equibles does not estimate personal net worth.

Get an email with a short summary when Aptargroup, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATR alerts

About Vanessa Kanu

Vanessa Kanu is recorded as CFO at Aptargroup, Inc. (ATR). Aptargroup, Inc. reported in an 8-K filed July 25, 2024 that Vanessa Kanu was appointed Executive Vice President, Chief Financial Officer, effective January 1, 2025. Vanessa Kanu has spoken on 7 earnings calls and 3 other investor events across 1 company, most recently for Aptargroup, Inc. on September 15, 2026. Aptargroup, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Aptargroup, Inc. includes Gael Touya (CEO and Board Member), Daniel Ackerman (Chief Accounting Officer), B. Craig Owens (Board Member) and 7 others.

“On July 25, 2024, the Company announced that Vanessa Kanu will succeed Mr. Kuhn as Executive Vice President, Chief Financial Officer of the Company, effective January 1, 2025.”
Aptargroup, Inc. Form 8-K, filed July 25, 2024 · Read the filing

Vanessa Kanu on recent calls

“So first of all, I definitely would not describe Aptar Pharma as a traditional packaging company. So when I first joined the company, you know, I have to tell you, I was very impressed by the breadth of the portfolio.”
CFO, Morgan Stanley 24th Annual Global Healthcare Conference ·
“Let me begin by summarizing the highlights for the quarter. Our reported sales increased 6% to approximately $1 billion, a new quarterly record. And core sales, which adjust for currency effects and acquisitions, increased 1% compared to the prior year.”
CFO, Aptar 2026 Q2 Results Earnings Call ·
“We have a presentation, which let me just make sure this clicker works.”
CFO, Wells Fargo 16th Annual Industrials & Materials Conference ·
“Thanks for taking the time to join us today and learn a little bit more about the Aptar So, if you haven't heard of us previously, then who is Aptar? We are a leader in drug consumer products, dosing, dispensing, and protection technologies.”
CFO, Jefferies Global Healthcare Conference ·
“Let me begin by summarizing the highlights for the quarter. Our reported sales increased 11%, and core sales, which adjust for currency effects and acquisitions, were flat compared to the prior year.”
CFO, Aptargroup, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Aptargroup, Inc.

Recent activity